AIMS: Lack of chronic kidney disease (CKD) awareness is common. Recent data suggest that the presence of concurrent diabetes may heighten CKD awareness, but current data have not supported the hypothesis that healthcare delivery or insurance status improves awareness in the diabetic population. Diabetes is associated with high cardiovascular disease (CVD) morbidity, especially in patients with CKD. We hypothesized that a highly prevalent co-morbid condition such as CVD in patients with diabetes would predict CKD awareness. METHODS: We utilized data from theNational Kidney Foundation-Kidney Early Evaluation Program (KEEPTM), a large screening program designed to identify high-risk individuals for CKD and promote awareness. RESULTS: Among 77,077 participants, CKD was identified in 20,200 and diabetes in 23,082. Prevalence of CVD was higher in participants with than without diabetes (39.5 vs. 22.0%) and in stage 3-5 compared to stage 1-2 CKD (43.3 vs. 34.4%). Patients with diabetes and CVD had a higher level of awareness than those without diabetes (8.2 vs. 2.2%). Among patients with diabetes and CVD, the presence of congestive heart failure was a better predictor of awareness [odds ratio (OR) 1.84; 95% confidence interval (CI) 1.40-2.43] than endpoints such as myocardial infarction or stroke [OR 1.35 (95% CI 1.04-1.73) and OR 1.34 (95% CI 1.04-1.72), respectively]. CONCLUSIONS: While prevalence of CKD awareness remained low, our data suggest that in patients with diabetes the presence of CVD was associated with increased awareness in a targeted screening program for CKD awareness.
AIMS: Lack of chronic kidney disease (CKD) awareness is common. Recent data suggest that the presence of concurrent diabetes may heighten CKD awareness, but current data have not supported the hypothesis that healthcare delivery or insurance status improves awareness in the diabetic population. Diabetes is associated with high cardiovascular disease (CVD) morbidity, especially in patients with CKD. We hypothesized that a highly prevalent co-morbid condition such as CVD in patients with diabetes would predict CKD awareness. METHODS: We utilized data from theNational Kidney Foundation-Kidney Early Evaluation Program (KEEPTM), a large screening program designed to identify high-risk individuals for CKD and promote awareness. RESULTS: Among 77,077 participants, CKD was identified in 20,200 and diabetes in 23,082. Prevalence of CVD was higher in participants with than without diabetes (39.5 vs. 22.0%) and in stage 3-5 compared to stage 1-2 CKD (43.3 vs. 34.4%). Patients with diabetes and CVD had a higher level of awareness than those without diabetes (8.2 vs. 2.2%). Among patients with diabetes and CVD, the presence of congestive heart failure was a better predictor of awareness [odds ratio (OR) 1.84; 95% confidence interval (CI) 1.40-2.43] than endpoints such as myocardial infarction or stroke [OR 1.35 (95% CI 1.04-1.73) and OR 1.34 (95% CI 1.04-1.72), respectively]. CONCLUSIONS: While prevalence of CKD awareness remained low, our data suggest that in patients with diabetes the presence of CVD was associated with increased awareness in a targeted screening program for CKD awareness.
Authors: Kraig S Kinchen; John Sadler; Nancy Fink; Ronald Brookmeyer; Michael J Klag; Andrew S Levey; Neil R Powe Journal: Ann Intern Med Date: 2002-09-17 Impact factor: 25.391
Authors: Wendy Weinstock Brown; Rosalind M Peters; Suzanne E Ohmit; William F Keane; Allan Collins; Shu-Chen Chen; Karren King; Michael J Klag; Donald A Molony; John M Flack Journal: Am J Kidney Dis Date: 2003-07 Impact factor: 8.860
Authors: Adam Whaley-Connell; James R Sowers; Peter A McCullough; Tricia Roberts; Samy I McFarlane; Shu-Cheng Chen; Suying Li; Changchun Wang; Allan J Collins; George L Bakris Journal: Am J Kidney Dis Date: 2009-04 Impact factor: 8.860
Authors: Claudine T Jurkovitz; Yang Qiu; Changchun Wang; David T Gilbertson; Wendy Weinstock Brown Journal: Am J Kidney Dis Date: 2008-04 Impact factor: 8.860
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Laura C Plantinga; L Ebony Boulware; Josef Coresh; Lesley A Stevens; Edgar R Miller; Rajiv Saran; Kassandra L Messer; Andrew S Levey; Neil R Powe Journal: Arch Intern Med Date: 2008-11-10
Authors: Annayya R Aroor; James R Sowers; Guanghong Jia; Vincent G DeMarco Journal: Am J Physiol Heart Circ Physiol Date: 2014-08-15 Impact factor: 4.733
Authors: Deepashree Gupta; Stephen Brietzke; M R Hayden; L Romayne Kurukulasuriya; James R Sowers Journal: Cardiorenal Med Date: 2011-10-13 Impact factor: 2.041
Authors: Adam T Whaley-Connell; Joseph A Vassalotti; Allan J Collins; Shu-Cheng Chen; Peter A McCullough Journal: Am J Kidney Dis Date: 2012-03 Impact factor: 8.860
Authors: Amit P Amin; Adam T Whaley-Connell; Suying Li; Shu-Cheng Chen; Peter A McCullough; Mikhail N Kosiborod Journal: Am J Kidney Dis Date: 2013-04 Impact factor: 8.860
Authors: F Fabbian; M Pala; A De Giorgi; A Scalone; C Molino; F Portaluppi; D P Mikhailidis; R Manfredini Journal: Open Cardiovasc Med J Date: 2011-11-18
Authors: Guntram Schernthaner; Naim Shehadeh; Alexander S Ametov; Anna V Bazarova; Fahim Ebrahimi; Peter Fasching; Andrej Janež; Péter Kempler; Ilze Konrāde; Nebojša M Lalić; Boris Mankovsky; Emil Martinka; Dario Rahelić; Cristian Serafinceanu; Jan Škrha; Tsvetalina Tankova; Žydrūnė Visockienė Journal: Cardiovasc Diabetol Date: 2020-10-23 Impact factor: 9.951